Definium Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Definium Therapeutics, Inc. (DFTX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 17.32 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- Definium Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 17.32M shares, a 1.30% increase year-over-year.
- Definium Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 18.47M shares, a 72.75% increase year-over-year.
- Definium Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 17.00M shares, a 170.51% increase year-over-year.
- Definium Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 17.10M shares, a 172.64% increase year-over-year.
- Definium Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 16.56M shares, a 50.95% increase from fiscal 2024.
- Definium Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 10.97M shares, a 12.20% decline from fiscal 2023.
- Definium Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 12.49M shares, a 2.14% increase from fiscal 2022.
- Definium Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 12.23M shares, a 227.09% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 17.32M shares 10-Q · filed 2026-08-06 | 17.32M shares 10-Q · filed 2026-08-06 | ||||
| 2026-03-31 | 18.47M shares 10-Q · filed 2026-05-07 | |||||
| 2025-12-31 | 16.56M shares 10-K · filed 2026-02-26 | |||||
| 2025-09-30 | 17.00M shares 10-Q · filed 2025-11-06 | 17.00M shares 10-Q · filed 2025-11-06 | ||||
| 2025-06-30 | 17.10M shares 10-Q · filed 2026-08-06 | 12.15M shares 10-Q · filed 2026-08-06 | ||||
| 2025-03-31 | 10.69M shares 10-Q · filed 2026-05-07 | 15.64M shares 10-Q · filed 2025-05-08 | ||||
| 2024-12-31 | 10.97M shares 10-K · filed 2026-02-26 | |||||
| 2024-09-30 | 6.29M shares 10-Q · filed 2025-11-06 | 12.28M shares 10-Q · filed 2025-11-06 | ||||
| 2024-06-30 | 6.27M shares 10-Q · filed 2025-07-31 | 12.26M shares 10-Q · filed 2025-07-31 | ||||
| 2024-03-31 | 13.44M shares 10-Q · filed 2025-05-08 | |||||
| 2023-12-31 | 12.49M shares 10-K · filed 2025-03-06 | |||||
| 2023-09-30 | 13.20M shares 10-Q · filed 2024-11-07 | 13.20M shares 10-Q · filed 2024-11-07 | ||||
| 2023-06-30 | 13.55M shares 10-Q · filed 2024-08-13 | 13.55M shares 10-Q · filed 2024-08-13 | ||||
| 2022-12-31 | 12.23M shares 10-K · filed 2024-02-28 | |||||
| 2021-12-31 | 3.74M shares 10-K · filed 2023-03-09 | 56.09M shares 10-K · filed 2022-03-28 | ||||
| 2020-12-31 | 39.56M shares 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |